AZOLE NUCLEOSIDES AND USE AS INHIBITORS OF RNA AND DNA VARIAL POLYMERASES

摘要

Azole nucleosides represented by the formulae (I) and (II); wherein A = C or N B = C or N X = H; C₁-C₆ alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, heterocyclo, halogen such as F, C1, Br and I; OH, NH₂, NH-(C₁-C₆ alkyl, cycloalkyl, aryl, or heterocyclo); Z = H; C₁-C₆ alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, heterocyclo, halogen such as F, Cl, Br, I; OH, NH₂, NH-(C₁-C₆ alkyl, cycloalkyl, aryl, or heterocyclo; E= (CH₂)HONHR¹; n is an integer from 0-6 and more typically 0-3; R¹= aryl or heterocyclo; each of W, Y, R is individually selected from the group consisting of H; C₁-C₆ alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, heterocyclo; halogen such as F, Cl, Br, and I; O, OH, Oalkyl, Oaryl, NH₂, NH-(C₁-C₆ alkyl, cycloalkyl, aryl, or heterocyclo); provided that at least one of W, Y, and R is other than H and wherein both W and Y together can be =O; and each D individually is OH, Oalkyl, Oaryl, Fl and H;pharmaceutically acceptable salts thereof, prodrugs thereof and mixtures thereof are provided. Compounds of this disclosure are useful as inhibitors of viral RNA and DNA polymerases such as, but not limited to, Influenza, Hantaan Virus, Crimean Congo hemorrhagic fever virus, hepatitis B, hepatitis C, Polio, Coxsackie A and B, Rhino, Echo, orthopoxvirus (small pox), HIV, Ebola, and West Nile virus polymerases; and especially orthopoxvirus, HIV, and hepatitis B.